Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Quest Diagnostics
(NY:
DGX
)
150.79
-0.59 (-0.39%)
Official Closing Price
Updated: 4:10 PM EDT, Oct 4, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
500,807
Open
152.11
Bid (Size)
150.12 (1)
Ask (Size)
151.31 (1)
Prev. Close
151.38
Today's Range
150.42 - 152.49
52wk Range
120.10 - 159.36
Shares Outstanding
122,180,759
Dividend Yield
1.88%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
What Analysts Are Saying About Quest Diagnostics Stock
August 27, 2024
Via
Benzinga
Diagnostic Giants Labcorp, Roche To Ramp Up Testing Capacity Amid Global Concerns Over New Mpox Strain
August 26, 2024
Labcorp considers boosting its mpox testing capacity as the WHO declares a global health emergency. Companies like Roche and Quest Diagnostics are also monitoring demand and expanding testing...
Via
Benzinga
Performance
YTD
+7.08%
+7.08%
1 Month
-2.96%
-2.96%
3 Month
+7.36%
+7.36%
6 Month
+15.43%
+15.43%
1 Year
+22.60%
+22.60%
More News
Read More
8 Health Care Stocks With Whale Alerts In Today's Session
August 01, 2024
Via
Benzinga
LabCorp's Stock Soars After Q2 Performance, Analyst Highlights Strong Position In Healthcare Sector
August 01, 2024
Via
Benzinga
Uncovering Dividend Opportunities with NYSE:DGX.
July 25, 2024
Via
Chartmill
5 Analysts Assess Quest Diagnostics: What You Need To Know
July 24, 2024
Via
Benzinga
Cracking The Code: Understanding Analyst Reviews For Quest Diagnostics
July 05, 2024
Via
Benzinga
How Is The Market Feeling About Quest Diagnostics?
June 27, 2024
Via
Benzinga
Quest Diagnostics' Q2 Earnings Performance Suggests Stable Stock, Modest Growth Ahead, Analyst Says
July 23, 2024
Via
Benzinga
Small-Cap Gains Resume Ahead Of Major Tech Earnings; UPS Faces Worst Day Ever, Bitcoin Dips Below $66,000: What's Driving Markets Tuesday?
July 23, 2024
Via
Benzinga
DGX Stock Earnings: Quest Diagnostics Beats EPS, Beats Revenue for Q2 2024
July 23, 2024
Via
InvestorPlace
Peering Into Quest Diagnostics's Recent Short Interest
June 10, 2024
Via
Benzinga
Analyst Scoreboard: 7 Ratings For Quest Diagnostics
May 30, 2024
Via
Benzinga
How Is The Market Feeling About Quest Diagnostics?
May 24, 2024
Via
Benzinga
US Stock Futures Little Changed As Traders Brace For Q2 Reports From Alphabet, Tesla: 'There Remains Strong Fundamental Support For Large Caps,' Says Economist
July 23, 2024
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Haystack Oncology and Lisata Therapeutics Initiate Research Collaboration to Use the Haystack MRD™ Technology to Evaluate Efficacy of Pancreatic Cancer Therapy
July 18, 2024
From
Lisata Therapeutics, Inc.; Quest Diagnostics, Haystack Oncology
Via
GlobeNewswire
Will Earnings Cheer Continue To Buoy Markets? Apple, Amazon, Pfizer, Coinbase Lead Flurry Of Q1 Reports This Week
April 29, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Peering Into Quest Diagnostics's Recent Short Interest
April 24, 2024
Via
Benzinga
Tesla, Alphabet, GM, Ford Lead Earnings Parade This Week As Market Struggles To Sustain The Summer Rally
July 21, 2024
Via
Benzinga
EXCLUSIVE: Haystack Oncology Inks Research Collaboration With Lisata Therapeutics To Use Haystack MRD Technology To Evaluate Pancreatic Cancer Therapy Efficacy
July 18, 2024
Via
Benzinga
S&P Global To Rally More Than 13%? Here Are 10 Top Analyst Forecasts For Friday
July 05, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Myriad Genetics Sees Stock Surge with Hereditary Cancer Tests
June 18, 2024
Via
MarketBeat
Employers Struggle with Drug Test Policies Amid Varying State Laws, Cheating on Drug Tests Reaches 30-Year High
May 15, 2024
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Intelligent Bio Solutions Screening Technologies Poised to Disrupt The Healthcare Sector: INBS, LH, ABT, DGX
April 30, 2024
Via
AB Newswire
Intelligent Bio Solutions’ Fingerprint Drug Screening Technology Poised For Massive Growth
April 25, 2024
Via
Talk Markets
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
